For citations:
Bragina O.D., Chernov V.I., Garbukov E.Yu., Zelchan R.V., Medvedeva A.A., Tolmachev V.M. Comparative Analysis of the Clinical Use of 99mTechnetium-Labeled Recombinant Target Molecules in Different Dosages for the Radionuclide Diagnosis of Her2-Positive Breast Cancer. Journal of radiology and nuclear medicine. 2021;102(2):89-97. (In Russ.) https://doi.org/10.20862/0042-4676-2021-102-2-89-97